Amicus Therapeutics
FOLD
FOLD
226 hedge funds and large institutions have $4.25B invested in Amicus Therapeutics in 2020 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 74 increasing their positions, 74 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
12% more funds holding
Funds holding: 202 → 226 (+24)
0% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 74
2.41% less ownership
Funds ownership: 111.82% → 109.41% (-2.4%)
Holders
226
Holding in Top 10
8
Calls
$43.4M
Puts
$4.23M
Top Buyers
| 1 | +$32.3M | |
| 2 | +$32.1M | |
| 3 | +$30.8M | |
| 4 |
D.E. Shaw & Co
New York
|
+$22.4M |
| 5 |
JP Morgan Chase
New York
|
+$20.8M |
Top Sellers
| 1 | -$67.9M | |
| 2 | -$60.8M | |
| 3 | -$27.7M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$22.6M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$18.5M |